The FDA said some of Boston Scientific ’s Endotak Reliance defibrillator wires can become calcified, which may stop the ...

U.S. health officials have issued warnings on two separate Boston Scientific heart devices recently linked to injuries and ...

A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...

Boston Scientific (BSX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

The FDA has issued an alert about a potentially high-risk issue involving models of Boston Scientific’s Watchman Access Systems, which are used to provide vascular and transseptal access during ...

Boston Scientific Corporation (NYSE:BSX) is one of the most profitable growth stocks to buy according to billionaires. On ...

Boston Scientific has outperformed the broader market over the past year, and analysts are highly optimistic about the ...

Boston Scientific has launched Endura Weight Loss Solutions, alongside survey findings showing that many U.S. women are ...

When considering lead replacement, physicians should weigh the risks and benefits of extraction versus abandonment.

Boston Scientific warned of the potential for rising low-voltage shock impedance (LVSI) associated with Reliance ...

This was the stock's second consecutive day of gains.

Boston Scientific’s revenues rose from $18.4 billion in 2019 to $20.2 billion in 2022, driven by an uptick in total procedures after a decline during the pandemic period.